Fuji mulls Given Imaging buying for up to $750M

Fujifilm Holdings is a chief suitor for Given Imaging, according to Israeli publication Calcalist.

On Oct. 17, Yoqneam, Israel-based Given Imaging announced it was evaluating a range of strategic options, including preliminary non-binding indications of interest received from a number of parties relating to a possible merger or sale.

Given Imaging stressed its intent to actively explore these and other alternatives, including a strategic alliance or additional acquisitions such as its recent acquisition of the assets of the Smart Pill. 

On Oct. 21, the Calcalist reported that Fujifilm is the key negotiator for the acquisition with a price that reflects a $750 million market cap for Given Imaging.

Given Imaging’s board of directors has appointed an executive committee consisting of the chairman and two independent directors to oversee the process. The investment banking firm Barclays is assisting the company in the process.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.